INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Public company

TPSTTempest Therapeutics, Inc.

CIK 0001544227

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells1 / 0
Max Insider Score47
Connections3with evidence

TPST · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
47
AM
Angel MatthewDirector, CEO and President, 10% Owner
TPSTTempest Therapeutics, Inc.
Open-market purchase
BUY$500K
231.5K sh
Mar 24, 2026Mar 25, 2026
traded Mar 24, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Angel MatthewDirector, CEO and President, 10% Owner · Feb 6, 2026
  • ← Insider ofevidence
    Simantov RonitDirector · Jan 28, 2026
9
AM
Angel MatthewDirector, CEO and President, 10% Owner
TPSTTempest Therapeutics, Inc.
Grant or award
A
—
269.6K sh
Feb 4, 2026
Feb 6, 2026
traded Feb 4, 2026
+2d
SEC FORM 4

Evidence

9
SR
Simantov RonitDirector
TPSTTempest Therapeutics, Inc.
Grant or award
A—
1,230 sh
Jan 27, 2026Jan 28, 2026
traded Jan 27, 2026
+1dSEC FORM 4

Evidence